Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-29
1995-12-12
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31415
Patent
active
054750040
ABSTRACT:
Antagonists for angiotensin II receptors of the AT.sub.1 subtype can be employed for the prophylaxis and combating of coronary heart disease.
Furthermore these compounds, such as, for example, azoles of the formula (I) ##STR1## can also be used for the therapy of cognitive and erectile dysfunction.
REFERENCES:
patent: 4355044 (1982-10-01), Heller
patent: 4766130 (1988-08-01), Austel et al.
patent: 4816463 (1989-03-01), Blankley et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 5332744 (1994-07-01), Chakravarty et al.
patent: 5334598 (1994-08-01), Bagley et al.
Takehiko et al., CA 116:6558 (EP Pat. 434038, 26 Jun. 1991).
Heitsch Holger
Kleemann Heinz-Werner
Wagner Adalbert
Wiemer Gabriele
Hoechst Aktiengesellschaft
Peabody John
Richter Johann
LandOfFree
Angiotensin II receptor antagonists for the treatment and prophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor antagonists for the treatment and prophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor antagonists for the treatment and prophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359966